ArticleJournal of translational medicine2016

MYC copy gain, chromosomal instability and PI3K activation as potential markers of unfavourable outcome in trastuzumab-treated patients with metastatic breast cancer.

Helen Gogas et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.